메뉴 건너뛰기




Volumn 73, Issue 2, 2009, Pages 302-309

Drug release from MCC- and carrageenan-based pellets: Experiment and theory

Author keywords

Carrageenan; Extrusion spheronisation; Microcrystalline cellulose; Pellets; Release mechanisms

Indexed keywords

3 [5 CHLORO 2 [2 [4 (4 FLUOROBENZYL) 2 METHYLPIPERAZIN 1 YL] 2 OXOETHOXY]PHENYL]URONIUM HYDROGEN SULFATE; CARRAGEENAN; CHEMOKINE RECEPTOR ANTAGONIST; CROSCARMELLOSE SODIUM; MACROGOL 6000; MICROCRYSTALLINE CELLULOSE; THEOPHYLLINE; UNCLASSIFIED DRUG; VATALANIB;

EID: 70349303798     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2009.05.007     Document Type: Article
Times cited : (49)

References (27)
  • 1
    • 0001960774 scopus 로고
    • Biopharmaceutical aspects of multiparticulates
    • Ghebre-Sellassie I. (Ed), Marcel Dekker Inc., New York
    • Krämer J., and Blume H. Biopharmaceutical aspects of multiparticulates. In: Ghebre-Sellassie I. (Ed). Multiparticulate Oral Drug Delivery (1994), Marcel Dekker Inc., New York 307-332
    • (1994) Multiparticulate Oral Drug Delivery , pp. 307-332
    • Krämer, J.1    Blume, H.2
  • 2
    • 9644254327 scopus 로고    scopus 로고
    • Pelletization techniques
    • Swarbrick J., and Boylan J.C. (Eds), Marcel Dekker Inc., New York
    • Ghebre-Sellassie I., and Knoch A. Pelletization techniques. In: Swarbrick J., and Boylan J.C. (Eds). Encyclopedia of Pharmaceutical Technology (2002), Marcel Dekker Inc., New York 2067-2080
    • (2002) Encyclopedia of Pharmaceutical Technology , pp. 2067-2080
    • Ghebre-Sellassie, I.1    Knoch, A.2
  • 3
    • 84905458717 scopus 로고    scopus 로고
    • Extrusion/spheronization
    • Ghebre-Sellassie I., and Martin C. (Eds), Marcel Dekker Inc., New York
    • Erkoboni K.A. Extrusion/spheronization. In: Ghebre-Sellassie I., and Martin C. (Eds). Pharmaceutical Extrusion Technology (2003), Marcel Dekker Inc., New York 277-322
    • (2003) Pharmaceutical Extrusion Technology , pp. 277-322
    • Erkoboni, K.A.1
  • 4
    • 0031001487 scopus 로고    scopus 로고
    • The crystallite gel model for microcrystalline cellulose in wet granulation, extrusion, and spheronization
    • Kleinebudde P. The crystallite gel model for microcrystalline cellulose in wet granulation, extrusion, and spheronization. Pharm. Res. 14 (1997) 804-809
    • (1997) Pharm. Res. , vol.14 , pp. 804-809
    • Kleinebudde, P.1
  • 5
    • 34247539538 scopus 로고    scopus 로고
    • Pharmaceutical approaches to preparing pelletized dosage forms using the extrusion-spheronization process
    • Trivedi N.R., Rajan M.G., Johnson J.R., and Shukla A.J. Pharmaceutical approaches to preparing pelletized dosage forms using the extrusion-spheronization process. Crit. Rev. Ther. Drug Carr. Syst. 24 (2007) 1-40
    • (2007) Crit. Rev. Ther. Drug Carr. Syst. , vol.24 , pp. 1-40
    • Trivedi, N.R.1    Rajan, M.G.2    Johnson, J.R.3    Shukla, A.J.4
  • 6
    • 0346352292 scopus 로고    scopus 로고
    • Extrusion and extruders
    • Swarbrick J., and Boylan J.C. (Eds), Marcel Dekker Inc., New York
    • Newton J.M. Extrusion and extruders. In: Swarbrick J., and Boylan J.C. (Eds). Encyclopedia of Pharmaceutical Technology (2002), Marcel Dekker Inc., New York 1220-1236
    • (2002) Encyclopedia of Pharmaceutical Technology , pp. 1220-1236
    • Newton, J.M.1
  • 7
    • 57349154376 scopus 로고    scopus 로고
    • Extrusion-spheronization without the incorporation of microcrystalline cellulose: a critical review
    • Dukic-Ott A., Thommes M., Remon J.P., Kleinebudde P., and Vervaet C. Extrusion-spheronization without the incorporation of microcrystalline cellulose: a critical review. Eur. J. Pharm. Biopharm. 71 (2009) 38-46
    • (2009) Eur. J. Pharm. Biopharm. , vol.71 , pp. 38-46
    • Dukic-Ott, A.1    Thommes, M.2    Remon, J.P.3    Kleinebudde, P.4    Vervaet, C.5
  • 9
    • 0030901260 scopus 로고    scopus 로고
    • Adsorption of ketotifen onto some pharmaceutical excipients
    • Al Nimry S.S., Assaf S.M., Jalal I.M., and Najib N.M. Adsorption of ketotifen onto some pharmaceutical excipients. Int. J. Pharm. 149 (1997) 115-121
    • (1997) Int. J. Pharm. , vol.149 , pp. 115-121
    • Al Nimry, S.S.1    Assaf, S.M.2    Jalal, I.M.3    Najib, N.M.4
  • 10
    • 0032696309 scopus 로고    scopus 로고
    • Formulation of ranitidine pellets by extrusion-spheronization with little or no microcrystalline cellulose
    • Basit A.W., Newton J.M., and Lacey L.F. Formulation of ranitidine pellets by extrusion-spheronization with little or no microcrystalline cellulose. Pharm. Dev. Technol. 4 (1999) 499-505
    • (1999) Pharm. Dev. Technol. , vol.4 , pp. 499-505
    • Basit, A.W.1    Newton, J.M.2    Lacey, L.F.3
  • 11
    • 23144446771 scopus 로고    scopus 로고
    • Extrusion/spheronization of pectin-based formulations. I. Screening of important factors
    • Tho I., Kleinebudde P., and Sande S. Extrusion/spheronization of pectin-based formulations. I. Screening of important factors. AAPS PharmSciTech 2 (2001)
    • (2001) AAPS PharmSciTech , vol.2
    • Tho, I.1    Kleinebudde, P.2    Sande, S.3
  • 12
    • 23144466482 scopus 로고    scopus 로고
    • Extrusion/spheronization of pectin-based formulations II. Effect of additive concentration in the granulation liquid
    • Tho I., Kleinebudde P., and Sande S. Extrusion/spheronization of pectin-based formulations II. Effect of additive concentration in the granulation liquid. AAPS PharmSciTech 2 (2001)
    • (2001) AAPS PharmSciTech , vol.2
    • Tho, I.1    Kleinebudde, P.2    Sande, S.3
  • 13
    • 0035985902 scopus 로고    scopus 로고
    • Pectinica acid, novel excipient for production of pellets by extrusion/spheronization: preliminary studies
    • Tho I., Sande S., and Kleinebudde P. Pectinica acid, novel excipient for production of pellets by extrusion/spheronization: preliminary studies. Eur. J. Pharm. Biopharm. 54 (2002) 95-99
    • (2002) Eur. J. Pharm. Biopharm. , vol.54 , pp. 95-99
    • Tho, I.1    Sande, S.2    Kleinebudde, P.3
  • 14
    • 0035997031 scopus 로고    scopus 로고
    • Quantum chemical descriptors in the formulation of pectin pellets produced by extrusion/spheronization
    • Tho I., Anderssen E., Dyrstad K., Kleinebudde P., and Sande S. Quantum chemical descriptors in the formulation of pectin pellets produced by extrusion/spheronization. Eur. J. Pharm. Sci. 16 (2002) 143-149
    • (2002) Eur. J. Pharm. Sci. , vol.16 , pp. 143-149
    • Tho, I.1    Anderssen, E.2    Dyrstad, K.3    Kleinebudde, P.4    Sande, S.5
  • 15
    • 0347985634 scopus 로고    scopus 로고
    • Production of chitosan pellets by extrusion/spheronization
    • Steckel H., and Mindermann-Nogly F. Production of chitosan pellets by extrusion/spheronization. Eur. J. Pharm. Biopharm. 57 (2004) 107-114
    • (2004) Eur. J. Pharm. Biopharm. , vol.57 , pp. 107-114
    • Steckel, H.1    Mindermann-Nogly, F.2
  • 16
    • 34548239869 scopus 로고    scopus 로고
    • Use of chitosan-alginate as alternative pelletization aid to microcrystalline cellulose in extrusion/spheronization
    • Charoenthai N., Kleinebudde P., and Puttipipatkhachorn S. Use of chitosan-alginate as alternative pelletization aid to microcrystalline cellulose in extrusion/spheronization. J. Pharm. Sci. 96 (2007) 2469-2484
    • (2007) J. Pharm. Sci. , vol.96 , pp. 2469-2484
    • Charoenthai, N.1    Kleinebudde, P.2    Puttipipatkhachorn, S.3
  • 17
    • 11144236165 scopus 로고    scopus 로고
    • The preparation by extrusion/spheronization and the properties of pellets containing drugs, microcrystalline cellulose and glyceryl monostearate
    • Chatchawalsaisin J., Podczeck J.F., and Newton J.M. The preparation by extrusion/spheronization and the properties of pellets containing drugs, microcrystalline cellulose and glyceryl monostearate. Eur. J. Pharm. Sci. 24 (2005) 35-48
    • (2005) Eur. J. Pharm. Sci. , vol.24 , pp. 35-48
    • Chatchawalsaisin, J.1    Podczeck, J.F.2    Newton, J.M.3
  • 18
    • 35348852075 scopus 로고    scopus 로고
    • Immediate release of poorly soluble drugs form starch-based pellets prepared by extrusion/spheronization
    • Dukic-Ott A., Remon J.P., Foreman P., and Vervaet C. Immediate release of poorly soluble drugs form starch-based pellets prepared by extrusion/spheronization. Eur. J. Pharm. Biopharm. 67 (2007) 715-724
    • (2007) Eur. J. Pharm. Biopharm. , vol.67 , pp. 715-724
    • Dukic-Ott, A.1    Remon, J.P.2    Foreman, P.3    Vervaet, C.4
  • 20
    • 9644303025 scopus 로고    scopus 로고
    • Preliminary assessment of carrageenan as excipient for extrusion/spheronization
    • Bornhoeft M., Thommes M., and Kleinebudde P. Preliminary assessment of carrageenan as excipient for extrusion/spheronization. Eur. J. Pharm. Biopharm. 59 (2005) 127-131
    • (2005) Eur. J. Pharm. Biopharm. , vol.59 , pp. 127-131
    • Bornhoeft, M.1    Thommes, M.2    Kleinebudde, P.3
  • 21
    • 33645882514 scopus 로고    scopus 로고
    • Use of κ-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. I. Influence of type and fraction of filler
    • Thommes M., and Kleinebudde P. Use of κ-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. I. Influence of type and fraction of filler. Eur. J. Pharm. Biopharm. 63 (2006) 59-67
    • (2006) Eur. J. Pharm. Biopharm. , vol.63 , pp. 59-67
    • Thommes, M.1    Kleinebudde, P.2
  • 22
    • 33645865531 scopus 로고    scopus 로고
    • Use of κ-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type
    • Thommes M., and Kleinebudde P. Use of κ-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type. Eur. J. Pharm. Biopharm. 63 (2006) 68-75
    • (2006) Eur. J. Pharm. Biopharm. , vol.63 , pp. 68-75
    • Thommes, M.1    Kleinebudde, P.2
  • 23
    • 36849030685 scopus 로고    scopus 로고
    • Properties of pellets manufactured by wet extrusion/spheronisation process using kappa-carrageenan: effect of process parameters
    • article 95
    • Thommes M., and Kleinebudde P. Properties of pellets manufactured by wet extrusion/spheronisation process using kappa-carrageenan: effect of process parameters. AAPS PharmSciTech 8 (2007) article 95
    • (2007) AAPS PharmSciTech , vol.8
    • Thommes, M.1    Kleinebudde, P.2
  • 24
    • 39749085696 scopus 로고    scopus 로고
    • The behavior of different carrageenans in pelletisation by extrusion/spheronization
    • Thommes M., and Kleinebudde P. The behavior of different carrageenans in pelletisation by extrusion/spheronization. Pharm. Dev. Technol. 13 (2008) 27-36
    • (2008) Pharm. Dev. Technol. , vol.13 , pp. 27-36
    • Thommes, M.1    Kleinebudde, P.2
  • 25
    • 34247520989 scopus 로고    scopus 로고
    • Effect of drying on extruded pellets based on kappa-carrageenan
    • Thommes M., Blaschek W., and Kleinebudde P. Effect of drying on extruded pellets based on kappa-carrageenan. Eur. J. Pharm. Sci. 31 (2007) 112-118
    • (2007) Eur. J. Pharm. Sci. , vol.31 , pp. 112-118
    • Thommes, M.1    Blaschek, W.2    Kleinebudde, P.3
  • 26
    • 0000409522 scopus 로고
    • Ueber die Aufloesungsgeschwindigkeit von festen Stoffen in ihren eigenen Loesungen
    • Noyes A.A., and Whitney W.R. Ueber die Aufloesungsgeschwindigkeit von festen Stoffen in ihren eigenen Loesungen. Z. Phys. Chem. 23 (1897) 689-692
    • (1897) Z. Phys. Chem. , vol.23 , pp. 689-692
    • Noyes, A.A.1    Whitney, W.R.2
  • 27
    • 0028837085 scopus 로고
    • Release of medicaments from spherical matrices containing drug in suspension: theoretical aspects
    • Koizumi T., and Panomsuk S.P. Release of medicaments from spherical matrices containing drug in suspension: theoretical aspects. Int. J. Pharm. 116 (1995) 45-49
    • (1995) Int. J. Pharm. , vol.116 , pp. 45-49
    • Koizumi, T.1    Panomsuk, S.P.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.